COCemal Ozemek

Cemal Ozemek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cemal Ozemek has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • Carl J. Lavie

    John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA

    8 shared publications
  • Ross Arena

    Department of Physical Therapy, College of Applied Health Sciences, University of Illinois, Chicago, IL, USA

    7 shared publications
  • Ross Arena

    University of Illinois Chicago

    6 shared publications
  • Carl J. Lavie

    Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA

    4 shared publications
  • Deepika Laddu

    3 shared publications
  • Joel Hardwick

    Department of Physical Therapy, University of Illinois at Chicago, College of Applied Health Sciences, Chicago, IL, USA

    3 shared publications

Latest Publications

  • Open Access

    Integrating sleep and circadian health into cardiac rehabilitation: A narrative review and practical framework for implementation

    by Amine Ghram, Javier Loureiro Diaz, Jari A. Laukkanen, Setor K. Kunutsor, Giuseppe Lippi, Tasuku Terada, Naima Covassin, Arto J. Hautala, Rasha Kaddoura, Linda S. Pescatello, et al.


  • Open Access

    Normative values for cardiopulmonary exercise testing in the pediatric population—an updated systematic review

    by Przemysław Kasiak, Tomasz Kowalski, Michele Zanini, Cemal Ozemek, Raphaël Faiss, Tadej Debevec, Artur Mamcarz, Daniel Śliż, Tomasz Chomiuk, Gian Luca Ragazzoni, et al.

    Aims: Normative data for cardiopulmonary exercise testing (CPET) provide benchmarks of aerobic fitness that change throughout the lifespan, with new scaling techniques often developed and differing between adults and children/adolescents. Considering the recent interest in the pediatric population for CPET studies, this systematic review aimed to update pediatric-specific CPET reference values. Methods and results: A systematic review was performed according to the PRISMA guidelines from 1 February 2019, to 31 December 2025, from six scientific databases. Observational studies in any language, presenting data from maximal CPET, and conducted only on healthy participants <18 years old were included. Primary outcomes included reference values for peak oxygen uptake (V̇O2peak), and secondary outcomes included other variables assessed during CPET. Risk of bias was assessed with the 14-point ATS/ACCP statement for CPET and the eight-point JBI Critical Appraisal Tool. 15 studies conducted on 12 083 participants [5886 (49.4%) females] were included, of which recruitment was hospital-based in six studies, community-based in eight studies, and athlete-specific in one study. Six studies reported ethnicity, with most participants classified as white, while one investigation presented exclusive data for obese/overweight or pediatric athletic cohorts. Normative V̇O2peak ranged between 26.0–56.3 mL·kg−1·min−1, peak heart rate between 175–199 bpm, and peak ventilation between 52.2–96.0 L·min−1. Reference equations were developed in 11 studies, with 5 of these studies validating the derived equations. A high heterogeneity was observed between studies of high (n = 2), moderate (n = 10), and low quality (n = 3), with ATS/ACCP statement and JBI Critical Appraisal Tool often disregarded—although quality level did not influence study outcomes. Conclusion: Updated normative values for CPET varied significantly in pediatric cohorts. While female representation matched male, and more studies considering pediatric athletes, showing a positive trend change from previous investigations, obese and overweight children/adolescents, as well as non-white participants, remained underrepresented. Considering the differences in normative data between pediatric cohorts of differing characteristics, clinicians should use reference values derived from cohorts closely matching their patients’ characteristics. PROSPERO registration number: CRD420251137402


  • Effects of High-Intensity Inspiratory Muscle Training on Cardiovascular Function in Patients With Heart Disease: A Randomized Controlled Pilot Study

    by Rıdvan Aktan, Richard Severin, Cemal Ozemek

    Purpose: The aim of this study was to investigate whether higher intensity inspiratory muscle training (HI-IMT), beyond usual clinical care, improves inspiratory muscle strength, endothelial function, arterial stiffness, functional exercise capacity, and perception of dyspnea in patients with heart disease. Methods: In this randomized controlled pilot study, 11 participants with heart disease were included. Participants were randomized to 4 weeks of either HI-IMT with a resistance set to 60% of baseline maximum inspiratory pressure (MIP) or sham-IMT without resistance (sham-control group). Endothelial function was assessed using flow-mediated dilation (FMD%), arterial stiffness using pulse wave velocity (PWV), functional exercise capacity using the 6-minute walk distance (6MWD), dyspnea perception using the modified Medical Research Council (mMRC) dyspnea scale, and inspiratory muscle strength using MIP. Results: There were no differences between groups for baseline demographic and clinical characteristics. Brachial FMD% (mean difference = 3.00%, P = .001), 6MWD (mean difference = 43.6 meters, P < .001), mMRC score (mean difference = −1.4 points, P < .001), and MIP (mean difference = 25.2 cmH 2 O, P < .001) values showed significant improvements in the HI-IMT group compared to the sham-controls. There was no significant difference between groups in PWV ( P = .107). Conclusions: HI-IMT produced improvements in inspiratory muscle strength, endothelial function, functional exercise capacity, and perception of dyspnea in patients with heart disease.


  • Open Access

    The Essential Role of Physical Activity in Healthy Living and Cardiovascular Disease: A Narrative Review

    by Cemal Ozemek, Joel Hardwick

    In its simplest definition, a healthy lifestyle is a way of living that lowers the risk of being seriously ill or dying early. There are many behaviors associated with living a healthy lifestyle, and understandably very few individuals in industrialized societies follow a lifestyle that facilitates the maintenance of an optimal body weight, physical activity (PA) levels, regular consumption of at least 5 portions of fruits and vegetables, abstain from smoking, and having moderate to no consumption of alcohol. To bring more attention to each of these elements, the American Heart Association identified 8 essential measures (PA, diet, blood glucose, weight, lipids, blood pressure, smoking status, and sleep quality) to maintain general and cardiovascular health. Following each of these behaviors and managing each of these measures drastically reduces one’s risk of developing cardiovascular disease (CVD). However, pursuing multiple behavior changes at once may prove to be burdensome to many individuals. Instead, selecting one and adding additional behaviors when ready is a preferred model. Among the various behaviors, PA has consistently been demonstrated to have numerous beneficial effects across physiologic systems. This review will therefore focus on the health benefits of PA and its role in CVD.


  • Evaluating current assessment techniques of cardiorespiratory fitness

    by Amanda R. Bonikowske, Jenna L. Taylor, Kathryn F. Larson, Joel Hardwick, Cemal Ozemek, Matthew P. Harber, Lenny A. Kaminsky, Ross Arena, Carl J. Lavie

    Considerable and convincing global data from cohorts across the health spectrum (i.e. apparently healthy to known disease) indicate that cardiorespiratory fitness (CRF) is a major predictor of overall and cardiovascular disease (CVD)-survival, seemingly with greater prognostic resolution compared to other traditional CVD risk factors. Therefore, the assessment of CRF in research and clinical settings is of major importance. In this manuscript, we review the technology of measuring CRF assessed by the 'gold standard,' cardiopulmonary exercise testing (CPET), as well as with various other methods (e.g. estimated metabolic equivalents, 6-minute walk tests, shuttle tests, and non-exercise equations that estimate CRF), all of which provide significant prognostic information for CVD- and all-cause survival. The literature through May 2024 has been cited. The promotion of physical activity in efforts to improve levels of CRF is needed throughout the world to improve lifespan and, more importantly, healthspan. The routine assessment of CRF should be considered a vital sign that is routinely assessed in clinical practice.


  • How to interpret a cardiorespiratory fitness assessment – Key measures that provide the best picture of health, disease status and prognosis

    by Cemal Ozemek, Joel Hardwick, Amanda Bonikowske, Jeffrey Christle, Charles German, Satyajit Reddy, Ross Arena, Mark Faghy


  • What has cardiac rehabilitation looked like in the COVID-19 pandemic: Lessons learned for the future

    by Cemal Ozemek, Robert Berry, Amanda R. Bonikowske, Charles German, Anne M. Gavic


  • Long-Term Maintenance of Cardiorespiratory Fitness Gains After Cardiac Rehabilitation Reduces Mortality Risk in Patients With Multimorbidity

    by Cemal Ozemek, Ross Arena, Codie R. Rouleau, Tavis S. Campbell, Trina Msc Hauer, Stephen B. Md Wilton, James Stone, Deepika Laddu, Tamara M. Msc Williamson, Hongwei Md Liu, et al.

    Purpose: The objective of this study was to characterize the impact of multimorbidity and cardiorespiratory fitness (CRF) on mortality in patients completing cardiac rehabilitation (CR). Methods: This cohort study included data from patients with a history of cardiovascular disease (CVD) completing a 12-wk CR program between January 1996 and March 2016, with follow-up through March 2017. Patients were stratified by the presence of multimorbidity, which was defined as having a diagnosis of ≥2 noncommunicable diseases (NCDs). Cox regression analyses were used to evaluate the effects of multimorbidity and CRF on mortality in patients completing CR. Symptom-limited exercise tests were completed at baseline, immediately following CR (12 wk), with a subgroup completing another test at 1-yr follow-up. Peak metabolic equivalents (METs) were determined from treadmill speed and grade. Results: Of the 8320 patients (61 ± 10 yr, 82% male) included in the analyses, 5713 (69%) patients only had CVD diagnosis, 2232 (27%) had CVD+1 NCD, and 375 (4%) had CVD+≥2 NCDs. Peak METs at baseline (7.8 ± 2.0, 6.9 ± 2.0, 6.1 ± 1.9 METs), change in peak METs immediately following CR (0.98 ± 0.98, 0.83 ± 0.95, 0.76 ± 0.95 METs), and change in peak METs 1 yr after CR (0.98 ± 1.27, 0.75 ± 1.17, 0.36 ± 1.24 METs) were different (P < .001) among the subgroups. Peak METs at 12 wk and the presence of coexisting conditions were each predictors (P < .001) of mortality. Improvements in CRF by ≥0.5 METS from baseline to 1-yr follow-up among patients with or without multimorbidity were associated with lower mortality rates. Conclusion: Increasing CRF by ≥0.5 METs improves survival regardless of multimorbidity status.


  • Right Ventricular Contractile Reserve: A Key Metric to Identifying When Cardiorespiratory Fitness Will Improve With Pulmonary Vasodilators

    by Ross Arena, Cemal Ozemek, Justin M. Canada, Carl J Lavie, Audrey Borghi-Silva, Samantha Bond, Dejana Popovic, Paola Argiento, Marco Guazzi